AVIR
Atea Pharmaceuticals
$4.27
+$0.10 (+2.4%)Oct 28, 2026
Key metrics
The numbers that frame AVIR today
- Market cap
- $342.47M
- ROIC
- -96.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $2.87
- 52wk High
- $6.45
Growth
Revenue and earnings trend for AVIR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AVIR
Is Atea Pharmaceuticals a good buy?
Hold. Atea Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Atea Pharmaceuticals is selling at a very high price.
What is the market capitalization of AVIR?
Atea Pharmaceuticals's market capitalization is $342.47M.
What is the 52-week high for AVIR stock?
The 52-week high for Atea Pharmaceuticals is $6.45. The current close of $4.27 is 33.8% below that high.
What is the 52-week low for AVIR stock?
The 52-week low for Atea Pharmaceuticals is $2.87. The current close of $4.27 is 48.8% above that low.
Does AVIR stock pay dividends?
Atea Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AVIR?
Atea Pharmaceuticals's Debt / Equity ratio is 0.